Optic Neuritis Market to Grow Substantially During the Forecast Period – Estimates DelveInsight | Key Companies – Questcor, Biogen, Mitochon Pharmaceuticals, and Noveome Biotherapeutics

Optic Neuritis Market to Grow Substantially During the Forecast Period - Estimates DelveInsight | Key Companies - Questcor, Biogen, Mitochon Pharmaceuticals, and Noveome Biotherapeutics
Delveinsight Business Research LLP
DelveInsight’s “Optic Neuritis Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Optic Neuritis Market Size and Share in the 7MM (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Optic Neuritis market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Optic Neuritis Market

Optic Neuritis: An Overview

The American Academy of Ophthalmology defined Optic Neuritis (ON) as the swelling of the eye’s optic nerve. The optic nerve carries light signals from the back of the eye to the brain so that a person can see. A person cannot see clearly if the optic nerve is swollen, damaged, or infected.

It is an acute rare disorder that usually occurs in one eye, and is characterized by symptoms including blurring of vision, a loss of part or all of central vision, reduced color vision, and dimness of vision. Most patients with ON have eye pain which characteristically worsens with movement of the eye.

Optic Neuritis Market Key Facts

  • As per The Transverse Myelitis Association, Optic Neuritis is a rare condition with an estimated annual incidence of 6.4 per 100,000 cases in the population in the United States. Also, the occurrence of Optic Neuritis tends to be the highest in populations located in higher latitudes (in the northern US and Western Europe) and is the lowest in regions closer to the equator.

  • In 15%-20% of people who eventually develop Multiple Sclerosis, Optic Neuritis is their first symptom. The risk of developing Multiple Sclerosis following one episode of Optic Neuritis is approximately 50% within 15 years of any first episode of Optic Neuritis. Various studies have shown that approximately 50% of patients who have Optic Neuritis for the first time will have magnetic resonance imaging (MRI) brain and/or spinal cord abnormalities consistent with MS at the time of the initial ON.

  • Optic Neuritis is most common among adults, aged 20 to 40 years, and its symptoms generally improve in 80 percent of patients over a few weeks. 

Optic Neuritis Market

As per DelveInsight, the Optic Neuritis market size is expected to increase during the forecast period owing to the launch of upcoming therapies.

The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Optic Neuritis market size by analyzing the impact of current and emerging therapies in the market. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the Optic Neuritis market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Optic Neuritis Epidemiology

The epidemiology section covers insights into the historical and current Optic Neuritis patient pool and forecasted trends for every seven major countries (7MM)  from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool, future trends, and assumptions undertaken.

Optic Neuritis Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Optic Neuritis market or expected to get launched during the study period. The analysis covers Optic Neuritis market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Optic Neuritis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Request for Sample PDF Report – https://www.delveinsight.com/sample-request/optic-neuritis-market

Optic Neuritis Therapeutics Analysis

Some of the key companies in the Optic Neuritis Market include:

  • Questcor

  • Biogen

  • Mitochon Pharmaceuticals

  • Noveome Biotherapeutics

And many more.

Optic Neuritis Therapies Covered in the Report Include:

  • Opicinumab

  • MP101

  • H.P. Acthar Gel (repository corticotropin) Injection

And others

Get More Detailed Insights Into the Emerging Therapies & Key Companies –  https://www.delveinsight.com/sample-request/optic-neuritis-market

Table of Content (TOC)

1. Key Insights

2. Executive Summary 

3. Optic Neuritis Competitive Intelligence Analysis

4. Optic Neuritis Market Overview at a Glance

5. Optic Neuritis Disease Background and Overview

6. Optic Neuritis Patient Journey

7. Optic Neuritis Epidemiology and Patient Population

8. Optic Neuritis Treatment Algorithm, Current Treatment, and Medical Practices

9. Optic Neuritis Unmet Needs

10. Key Endpoints of Optic Neuritis Treatment

11. Optic Neuritis Marketed Products

12. Optic Neuritis Emerging Therapies

13. Optic Neuritis Seven Major Market Analysis

14. Attribute Analysis

15. Optic Neuritis Market Outlook (7 major markets)

16. Optic Neuritis Access and Reimbursement Overview

17. KOL Views on the Optic Neuritis Market.

18. Optic Neuritis Market Drivers

19. Optic Neuritis Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Download Sample PDF Report – https://www.delveinsight.com/sample-request/optic-neuritis-market

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Other Latest Reports By DelveInsight

Decompensated Cirrhosis Market 

DelveInsight’s “Decompensated Cirrhosis Market” report delivers an in-depth understanding of the Decompensated Cirrhosis, historical and forecasted epidemiology as well as the Decompensated Cirrhosis market size, share, and trends in the 7MM

Media Contact
Company Name: DelveInsight Business Research
Contact Person: Shruti Thakur
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/